The cancer stem cell (CSC) hypothesis proposes that CSCs are responsible for metastasis and disease recurrence. Therefore, targeting CSCs has the potential to significantly improve outcomes for cancer patients. The OCT4 transcription factor gene is a master gene that plays a key role in the self-renewal and pluripotency of stem cells. In this study, we introduced an OCT4 reporting vector into 4T1 mouse breast cancer cells and sorted OCT4 high and OCT4 low cell populations. We then determined whether OCT4 expression is associated with maintenance and expansion of CSCs. We found that OCT4 high 4T1 cells have an increased ability to form tumorsphere and a high expression of stem cell markers such as Sca-1, CD133, CD34, and ALDH1, when compared with OCT4 low 4T1 cells. In addition, OCT4 high 4T1 cells have greater tumorigenic potential in vivo. These findings suggest that OCT4 expression may be a useful target for stem cell-specific cancer therapy.
The cancer stem cell (CSC) hypothesis proposes that CSCs, which constitute a small population of cells within a tumor, are able to self-renew and to give rise to diverse cellular progeny. Indeed, CSCs may be responsible for the escape of tumors from conventional therapies, resulting in residual CSCs that can lead to disease recurrence and metastasis [1] [2] [3] . Therefore, CSC-specific therapies might prevent cancer relapse and completely destroy cancer at its root.
The OCT4 (also known as POU5F1) transcription factor gene is known as a master pluripotency gene [4, 5] . Kim and colleagues showed that OCT4 alone is sufficient to directly reprogram adult mouse neural stem cells to pluripotent stem (iPS) cells [6] . Clinical studies have shown that tumors with intense expression of the OCT4 stem cell marker are associated with further disease progression, greater metastasis, and shorter cancer-related survival compared with tumors with moderate and low OCT4 expression [7] . Furthermore, OCT4 is reported to be a core regulator of stem cell selfrenewal and differentiation, and was recently validated as a CSC target [8] . Based on these findings, our study attempts to identify the CSC population characterized by the OCT4 phenotype among 4T1 mouse breast cancer cells. To this end, we stably infected 4T1 cells with a retroviral particle which contains the mouse OCT4 promoter and drives expression of red fluorescent protein (RFP). The goal was to determine whether targeting of OCT4 expression is a feasible strategy for stem specific cancer therapy in a rigorously defined mouse 4T1 breast tumor model.
Materials and Methods

Cell culture
Mouse breast cancer cell lines (67NR and 4T1) and human breast cancer cell lines (MCF-7, T-47D, MDA-MB-231, and Hs578T) were cultured in DMEM (Invitrogen, Grand Island, NY, USA) containing 10% FBS and 1% penicillin /streptomycin (Invitrogen), as previously described [9] [10] [11] . The 4T1-Luc-OCT4 cell line was established by infection of 4T1-Luc cells (Caliper Life Sciences, Hopkinton, MA, USA) with a mouse OCT4-pRFPZeo packaged virus particle (System Biosciences, Mountain View, CA, USA) according to the manufacturer's protocol. Stable transfectants were selected by incubation with zeocin (300 mg/mL, Invitrogen), and OCT4 expression was determined using a fluorescent microscope (Carl Zeiss, Thornwood, NY, USA).
Flow cytometry
FACS analysis and sorting were performed using a FACS Calibur and FACSAria (Becton Dickinson, Franklin Lakes, NJ, USA), respectively. FACS data were analyzed using Flowjo software (Tree Star, Ashland, OR, USA). The Aldefluor kit (Stem Cell Technologies, Vancouver, Canada) was used to isolate a population with high aldehyde dehydrogenase (ALDH) enzymatic activity, according to the manufacturer's instructions. The following antibody was used: OCT4 (Abcam, Cambridge, MA, USA). An APC-conjugated rabbit IgG antibody (Molecular Probes, Eugene, OR, USA) was used for visualization.
Tumorsphere culture
Tumor sphere culturing was performed as previously described [12, 13] . After 7 to 10 days of culturing, wells were examined under an inverted microscope at x50 magnification, and the number and diameter of spheres was determined for independent fields per well using the Image-Pro Plus program (Media Cybernetics, Bethesda, MD, USA).
In vivo limiting dilution assay
All animals were maintained according to IACUC approved protocols of the Lee Gil Ya Cancer and Diabetes Institute, Korea. For titration experiments, the left and right thoracic (#2) mammary fat pads (m.f.p.) of anesthetized 7-week-old female Balb/c mice (Orient Charles River Technology, Seoul, Korea) were surgically exposed and sorted 4T1 cells were inoculated into m.f.p. in a 50 mL volume (n=3/group). Tumor incidence was assessed via in vivo bioluminescence measurement using an IVIS Imaging System (Caliper Life Sciences). For luciferase detection, 150 mg/mL D-luciferin (Caliper Life Sciences) in PBS was injected intraperitoneally before imaging. Photometric measurement of tumors was done by Living Image software (V. 3.1.0, Caliper Life Sciences).
Quantitative reverse-transcription-polymerase chain reaction (RTQ-PCR)
RTQ-PCR for quantification of cDNA was performed using 
Statistical analysis
All experiments were done 3 or more times, and the results are expressed as mean±SD. Statistical analyses of these data were done using an unpaired Student's t-test for parametric analysis or the Mann-Whitney U test for nonparametric analysis.
Results
The ALDH
pos CSC population has a high OCT4 expression
The expression of ALDH as assessed by the Aldefluor assay has been recognized as a marker for malignant stem cells in breast cancers [14] . To evaluate OCT4 expression in the CSC population characterized by high ALDH activity, we compared the expression of OCT4 in ALDH neg and ALDH 
OCT4
high 4T1 cell population has high tumorsphere forming ability It has been reported that cancer stem-cell like cells can be cultured in vitro to test stem cell properties such as selfrenewal in serum-free medium with bFGF and EGF [12] .
To determine whether 4T1 cells showing OCT4
high have high sphere-forming ability, we introduced an OCT4-RFP vector into 4T1-Luc cells ( Figure 1A ), sorted 4T1-Luc cells into OCT4 low and OCT4 high cell population, and plated the freshly isolated cell populations under tumorsphere forming culture conditions (Figure 2A ). Only the OCT4 high cell population grew into typical spheres and they showed much larger and greater numbers of spheres than did the OCT4 low cell population ( Figure 2B ).
OCT4
high 4T1 cell population has more tumorigenic potential in vivo in immune-competent mice To investigate the in vivo tumorigenic ability of OCT4 high cell population, we injected sorted cells into the mammary glands of mice. As shown in Table 1 an increase (~2-fold) in bioluminescence in the primary tumor generated by OCT4 high 4T1-Luc cells, compared with OCT4 low 4T1-Luc cells (Figure 3 ). These results demonstrate that the OCT4 high cell population has more tumorigenic potential in vivo in an immune competent microenvironment.
The OCT4 high 4T1 cell population has high expression of stem cell markers
To further characterize the OCT4
high cell population, we compared expression profiles of stem cell marker genes [13] [14] [15] [16] [17] [18] in OCT4 low and OCT4 high cell population sorted from 4T1-Luc cells. RTQ-PCR analysis showed significant increases (~2-fold to 3-fold) for Sca-1, CD133, CD34 and ALDH1 expression but no significant change in CD90 expression in the OCT4 high cell population over the OCT4 low cell population (Figure 4 ). Taken together, these results show that the expression of stem cell markers is highly increased in the OCT4 high cell population.
Discussion
The OCT4 gene, a member of the POU family of transcription factors, was shown to be expressed in stem cells [19, 20] . In this study, we applied OCT4 positive cell analysis and sorting to cause enrichment in putative CSCs in the 4T1 mouse model. The 4T1 breast cancer model is widely considered to be one of the best syngeneic xenograft mouse models for the study of human cancer progression [21, 22] . To our knowledge, this is the first report that OCT4 may be a good marker for CSC characterization in an immunecompetent syngeneic tumor microenvironment. This conclusion was supported by the following findings. First, the size of the OCT4 high cell population isolated from 4T1 cells was positively correlated with tumorigenicity in immunecompetent mice compared with the OCT4 low cell population.
Second, CSCs expressing OCT4 displayed high tumorsphere forming ability in vitro. Third, the OCT4 high cell population had high expression of stem cell markers compared with the OCT4 low cell population.
Self-renewal and pluripotency are central features in the definition of stem cell populations, and OCT4 is a key regulator in these processes [19, 23] . Further, the expression of OCT4 has been shown in human breast cancer stem-like cells, implicating its involvement in self-renewal and tumorigenesis [24] . Recently, Hu and colleagues suggested that a reduction in OCT4 expression in lung CSCs induces apoptosis and the inhibition of tumor growth partly through the OCT4/Tcl1/ Akt1 pathway [8] . In addition, OCT4 was recently reported to play a critical role in survival/apoptosis of embryonic stem cells via stat3/survivin [25] . However, the detailed molecular roles of OCT4 in cancer stemness have not yet been fully elucidated. Therefore, additional studies are necessary to look into downstream molecular mechanisms by which OCT4 regulates the maintenance and expansion of CSCs.
In summary, the present work suggests that high expression of OCT4 enhances stem cell properties in a mouse model of breast cancer. Thus, OCT4 may represent a target molecule for the treatment of advanced cancer. 
